The differences in RCAS1 and DFF45 endometrial expression between late proliferative, early secretory, and mid-secretory cycle phases

Folia Histochemica et Cytobiologica

Volumn 45, Issue SUPPL. 1, 2007, Pages 157-162

  Popiela, Tadeusz J ^a   Wicherek, Lukasz ^a   Radwan, Michal ^b   Sikora, Jerzy ^c   Banas, Tomasz ^a   Basta, Pawel ^a   Kulczycka, Magdalena ^a   Grabiec, Marek ^d   Obrzut, Bogdan ^e   Kalinka, Jaroslaw ^b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^e UNIVERSITY OF RZESZÓW   (Poland)

Author keywords

DFF45; Endometrium; Menstrual cycle phases; RCAS1

Indexed keywords

PROTEIN; PROTEIN DFF45; PROTEIN RCAS1;

ADULT; CONFERENCE PAPER; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MENSTRUAL CYCLE; NIDATION; OVULATION; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 43849109118     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Lessey BA, Castelbaum AJ, Wolf L et al. Use of integrins to date the endometrium. Fertil Steril. 2000;73:779-787.
2. Noyes RW, Hertig AI, Rock J. Dating the endometrial biopsy. Fertil Steril. 1950;1:3-25.
3. Ledee-Bataille N, Bonnet-Chea K, Hosny G, Dubanchet S, Frydman R, Chaouat G. Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure. Fertil Steril. 2005;83:598-605.
4. Dimitriadis E, Stoikos C, Stafford-Bell M, et al. Interleukin-11, IL-11 receptoralpha and leukemia inhibitory factor are dysregulated in endometrium of infertile women with endometriosis during the implantation window. J Reprod Immunol. 2006;69:53-64.
5. Aghajanova L, Stavreus-Evers A, Nikas Y, Hovatta O, Landgren BM. Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium. Fertil Steril. 2003;79:808-814.
6. Kitaya K, Yamaguchi T, Honjo H. Central role of interleukin-15 in postovulatory recruitment of peripheral blood CD16(-) natural killer cells into human endometrium. J Clin Endocrinol Metab. 2005;90:2932-2940.
7. Kitaya K, Yasuda J, Yagi I, Tada Y, Fushiki S, Honjo H. IL-15 expression at human endometrium and decidua. Biol Reprod. 2000;63:683-687.
8. Roberts M, Luo X, Chegini N. Differential regulation of interleukins IL-13 and IL-15 by ovarian steroids, TNF-alpha and TGF-beta in human endometrial epithelial and stromal cells. Mol Hum Reprod. 2005;11:751-760.
9. Goumenou AG, Matalliotakis IM, Tzardi M, Fragouli YG, Mahutte NG, Arici A. Apoptosis and differential expression of apoptosis-related proteins in endometriotic glandular and stromal cells. J Soc Gynecol Investig. 2004;11:318-322.
10. Hornung D, Klingel K, Dohrn K, Kandolf R, Wallwiener D, Taylor RN. Regulated on activation, normal T-cell-expressed and -secreted mRNA expression in normal endometrium and endometriotic implants: assessment of autocrine/paracrine regulation by in situ hybridization. Am J Pathol. 2001;158:1949-1954.
11. Stavreus-Evers A, Koraen L, Scott JE, Zhang P, Westlund P. Distribution of cyclooxygenase-1, cyclooxygenase-2, and cytosolic phospholipase A2 in the luteal phase human endometrium and ovary. Fertil Steril. 2005;83:156-162.
12. Steck T, Giess R, Suetterlin MW, Bolland M, Wiest S, Poehls UG, Dietl J: Leukaemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer. Eur J Obstet Gynecol Reprod Biol. 2004;112:69-73.
13. Linjawi S, Li TC, Tuckerman EM, Blakemore AI, Laird SM. Expression of interleukin-11 receptor alpha and interleukin-11 protein in the endometrium of normal fertile women and women with recurrent miscarriage. J Reprod Immunol. 2004;64:145-155.
14. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol. 2000;47:87-103.
15. Pongcharoen S, Searle RF, Bulmer JN. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy. Placenta. 2004;25:321-330.
16. Joswig A, Gabriel HD, Kibschull M, Winterhager E. Apoptosis in uterine epithelium and decidua in response to implantation: evidence for two different pathways. Reprod Biol Endocrinol. 2003;1:44.
17. Qiu Q, Yang M, Tsang BK, Gruslin A. Fas ligand expression by maternal decidual cells is negatively correlated with the abundance of leukocytes present at the maternal-fetal interface. J Repord Immunol. 2005;65:121-132.
18. Harada T, Kaponis A, Iwabe T et al. Apoptosis in human endometrium and endometriosis. Hum Reprod Update. 2004; 10:29-38.
19. Sonoda K, Miyamoto S, Hirakawa T et al. Clinical significance of RCAS1 as a biomarker of uterine cancer. Gynecol Oncol. 2006; 103:924-931.
20. Sonoda K, Miyamoto S, Hirakawa T et al. Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol. 2005;97:772-779.
21. Kawano Y, Kaku T, Sonoda K et al. Expression of RCAS1 in female genital organs. Int J Gynecol Pathol. 2005;24,330-334.
22. Wicherek L, Popiela TJ, Galazka K et al. Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and endometrium according to menstrual cycle changes. Gynecol Oncol. 2005;99:622-630.
23. Wicherek L, Galazka K, Klimek M, Obrzut B. Cycle dependent RCAS1 expression with respect to the immune cells presence and activity. Neuro Endocinol Lett. 2006;27: 645-650.
24. Wicherek L, Galazka K, Lazar A. RCAS1 decidual immunoreactivity during placental abruption immune cell presence and activity. Am J Reprod Immunol. 2007; 58:46-55.
25. Sonoda K, Miyamoto S, Manabu Nakashima M, Wake N. Biological role of the unique molecule rcas1: a bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis. Front Biosci. 2008;13:1106-1111.
26. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med. 1999;5:938-942.
27. Sonoda K, Miyamoto S, Hirakawa T et al. Invasive potency related to RCAS1 expression in uterine cervical cancer. Gynecol Oncol. 2005;99:189-198.
28. Tabibzadeh S. Decoding implantation and menstruation: the tale of opposing signals. Front Biosci. 2002;7:1475-1486.
29. Banas T, Wicherek L, Popiela TJ et al. Comparative analysis of DFF45 expression between eutopic and ectopic endometrium. Pol J Environ Stud. 2005;14,Suppl 2:410-420.
30. Widlak P. DNA microarrays, a novel approach in studies of chromatin structure. Acta Biochim Pol. 2004;51:1-12.
31. Zhou P, Lugovskoy AA, Mccarty JS, Li P, Wagner G. Solution structure of DFF40 and DFF45 N-terminal domain complex and mutual chaperone activity of DFF40 and DFF45. Proc Natl Acad Sci USA. 2001;98:6051.
32. Zhang J, Wang X, Bove KE, Xu M. DNA fragmentation factor 45-deficient cells are more resistant to apoptosis and exhibit different dying morphology than wild-type control cells. J Biol Chem. 1999;274:37450-37459.
33. Konishi S, Ishiguro H, Shibata Y et al. Decreased expression of DFF45 is correlated with a poor prognosis in patient with esophageal carcinoma. Cancer. 2002;95:2473-2479.
34. Wicherek L, Dutsch-Wicherek M, Mak P, Klimek M, Skladzien J, Dubin A. Comparative analysis of RCAS1 level in neoplasms and placenta. Acta Biochim Pol. 2003;50:1187-1194.
35. Dutsch-Wicherek M, Tomaszewska R, Strek P, Wicherek L, Skladzien J. The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration. BMC Immunol. 2006;7:4.
36. Tabibzadeh S. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol Hum Reprod. 1996;2:77-92.
37. Watanabe H, Kanzaki H, Narukawa S t al. Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am J Obstet Gynecol. 1997;176:360-368.
38. Sharif-Askari E, Alam A, Rheaume E et al. Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. EMBO J 2001;20:3101-3110.
39. Chen WJ. Dendritic Cells and CD4+CD25+ T Regulatory Cells: Crosstalk Between Two Professionals in Immunity versus Tolerance. Front Biosci. 2006;11:1360-1370.
40. Sharma S, Murphy SP, Barnea ER. Genes regulating implantation and fetal development: a focus on mouse knockout models. Front Biosci. 2006;11:2123-2137.
41. Garai J, Molnar V, Varga T, Koppan M, Torok A, Bodis J. Endometriosis: harmful survival of an ectopic tissue. Fornt Biosci. 2006; 11:595-619.
42. Tabibzadeh S. Molecular control of the implantation window. Hum Reprod Update. 1998;4:465-471.
43. Tang M, Xu Y, Julian J, Carson D, Tabibzadeh S. Lefty is expressed in mouse endometrium in estrous cycle and periimplantation period. Hum Reprod. 2005;20: 872-880.
44. Mason JM, Xu H-P, Rao SK et al. Lefty contributes to the remodeling of extracellular matrix by inhibition of connective tissue growth factor and collagen mRNA expression and increased proteolytic activity in a fibrosarcoma model. J Biol Chem. 2002;277:407-415.
45. Goldamn S, Shalev E. The role of the matrix metalloproteinases in human endometrial and ovarian cycles. Eur J Obstet Gynecol Reprod Biol. 2003;11:109-121.
46. Kalinka J, Sobala W, Wasiela M, Brzezinska-Blaszczyk E. Decreased proinflmatory cytokines in cervicovaginal fluid as measured in midgestation, are associated with preterm delivery. Am J Reprod Immunol. 2005;54:70-76.
47. Ordi J, Casals G, Ferrer B et al. Uterine (CD56+) natural Killer cells recruitment: association with decidual reaction rather than embryo implantation. Am J Reprod Immunol. 2006;55:369-377.
48. Kayisli UA, Guzeloglu-Kayisli O, Arici A. Endocrine-immune interactions in human endometrium. Ann N Y Acad Sci. 2004;1034:50-63.
49. Wicherek L. The role of the endometrium in the regulation of immune cell activity. Front Biosci. 2008;13:1018-1035
50. Sonoda K, Kaku T, Hirakawa T et al. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Gynecol Oncol. 2000;79:424-429.